Table 1.

Demographics and clinical features of reported cases.

N.	Sex, age (years)	Vaccine	Concomitant medications	Latency from the 1st dose (days)	Naranjo score#	Baseline BPDAI	Baseline ABSIS	Treatment	BPDAI at 3 months	ABSIS at 3 months
1	F, 84	Pfizer	Alendronate	25	6	70	21	Topical and systemic CS plus doxycycline	0	0
2	M, 83	Pfizer	Allopurinol, amiodarone, amlodipine, bicalutamide, clonidine, furosemide, insulin, valsartan, warfarin	32	6	50	18	Topical and systemic CS plus doxycycline	0	0
3	F, 56	Moderna	none	7	6	17	4.5	Topical CS plus doxycycline	0	0
4	M, 79	Pfizer	ASA, amiodarone, atorvastatin, clopidogrel, hydrochlorothiazide, olmesartan, pantoprazole, tamsulosin	4	6	23	10	Topical CS plus doxycycline	0	0
5	M, 86	Pfizer	Amiodarone, atorvastatin, clopidrogrel, domperidone, escitalopram, hydrochlorothiazide, levodopa/benserazide	37	6	20	12	Topical CS	0	0
6	M, 91	Pfizer	Allopurinol, atorvastatin, furosemide, insulin, nebivolol	28	6	80	30	Topical and systemic CS	0	0
7	M, 86	Pfizer	ASA, fenofibrate, isosorbide, ivabradine, pyridostigmine	36	6	52	20	Topical and systemic CS plus doxycycline	0	0
8	F, 84	Moderna	Amlodipine, glimepiride, metformin, levothyroxine	7	6	40	15	Topical and systemic CS plus doxycycline	0	0
9	M, 84	Pfizer	None	23	6	37	54	Systemic CS	0	0
10	F, 82	Pfizer	None	34	6	52	90	Systemic CS	6	27
11	M, 76	Pfizer	Candesartan, hydrochlorothiazide	34	6	47	70	Systemic CS	NA	NA
12	M, 78	Pfizer	none	4	4	42	NA	Topical CS	0	NA
13	F, 90	Pfizer	Allopurinol, hydrochlorothiazide, losartan	28	4	142	NA	Topical and systemic CS	25	NA
14	M, 90	Pfizer	Alfuzosin, allopurinol, darbepoetin alfa, furosemide, levothyroxine, pregabalin, warfarin	64	6	20	NA	Systemic CS	0	NA
15	M, 72	Pfizer	Insulin, telmisartan	16	6	80	NA	Topical and systemic CS plus MTX	29	NA
16	M, 80	Pfizer	ASA, amlodipine, atenolol, atorvastatin, finasteride, salmeterol/fluticasone, zofenopril	6	6	71	90	Topical and systemic CS	51	70
17	F, 77	AstraZeneca	Amlodipine, bisoprolol, furosemide, ramipril, sertraline	3	8	42	60	MTX	0	0
18	F, 60	Pfizer	None	75	6	10	36	Systemic CS	0	0
19	F, 70	Pfizer	None	27	6	15	35	Systemic CS	1	5
20	F, 72	AstraZeneca (1st dose), Pfizer (2nd dose)	ASA, amlodipine, levothyroxine, perindopril, simvastatin	7	6	15	NA	Systemic CS plus dapsone	3	NA
21	M, 85	Pfizer	ASA, atenolol, dutasteride, indapamide, perindopril, tamsulosin	27	6	15	30	Systemic CS	41	50

^#Naranjo scale interpretation: doubtful (≤0), possible (1-4), probable (5-8), definite (≥9).

CS, corticosteroids; MTX, methotrexate; NA, not available; ABSIS, Autoimmune Bullous Skin Disorder Intensity Score; ASA, acetylsalicylic acid; BPDAI, Bullous Pemphigoid Disease Area Index.